摘要
In a recent study published in Nature,Griffin et al.reported that blockade of SETDB1 enhances anti-tumor immune response,shedding new light on the potential epigenetic therapy to specifically improve immune checkpoint blockade(ICB)effectiveness.
基金
This work was supported by grants from the National Natural Science Foundation of China(81788101).
